Futhan® is the commercial brand name of Nafamostat Mesilate for Injection, a synthetic serine protease inhibitor. It blocks a wide range of proteases such as trypsin, kallikrein, thrombin and plasmin, thereby restraining excessive inflammatory response and abnormal coagulation activation. Main…
Saiweijian® is the commercial brand name of Raltitrexed for Injection, a folate antimetabolite cytotoxic agent developed by Chia Tai Tianqing. It inhibits thymidylate synthase, disrupting DNA synthesis and thereby suppressing tumor cell proliferation. Main IndicationsFor the treatment of advanced colorectal…
Ruixinshuo® is the commercial brand name of Risperidone Microspheres for Injection (II), a long-acting injectable atypical antipsychotic developed by Luye Pharma. It works by blocking dopamine D2 and serotonin 5-HT2A receptors, delivering sustained release of risperidone after intramuscular administration to…
Amphotec® is the commercial brand name of Amphotericin B Cholesteryl Sulfate Complex for Injection, a lipid formulation of amphotericin B. It binds to ergosterol within fungal cell membranes, disrupting membrane integrity and leading to fungal cell death. This lipid complex…
Ruitaning® is the commercial brand name of Fosrolapitant and Palonosetron Hydrochloride for Injection, a fixed-combination antiemetic injection developed by Hengrui Medicine. It consists of fosrolapitant, a long-acting NK-1 receptor antagonist, and palonosetron, a 5-HT3 receptor antagonist, to block two key…
Romiplate® is the commercial brand name of Romiplostim for Injection, a thrombopoietin receptor agonist developed by Kyowa Kirin. It binds to the thrombopoietin receptor on megakaryocytes, promoting megakaryocyte proliferation and maturation, thereby increasing platelet count. Main IndicationsTreatment of adult patients…
Lidaxing® is the commercial brand name of Perflutren Human Albumin Microspheres for Injection, a lyophilized ultrasound contrast agent developed by Xiamen Likang Pharmaceutical. After intravenous injection, the microspheres can enhance the backscatter of ultrasound signals, improving the visualization of endocardial…
Avida® is the commercial brand name of Trastuzumab Rezetecan for Injection, an antibody-drug conjugate (ADC) developed by Hengrui Medicine. It targets HER2 antigen on tumor cell surface, binds specifically to HER2, then internalizes into tumor cells and releases cytotoxic payload…
Enzeshu® is the commercial brand name of Suvemcitug for Injection, a fully human monoclonal antibody developed by Simcere Pharmaceutical. It targets IL-4Rα, blocking the signaling of IL‑4 and IL‑13, two key type 2 inflammatory cytokines, thereby suppressing type 2 inflammatory…
TaiAi® is the commercial brand name of Telitacicept for Injection, a recombinant fusion protein developed by Rongchang Biotech. It simultaneously binds to BAFF and APRIL, inhibiting the activation and maturation of B lymphocytes and reducing autoantibody production to modulate abnormal…